Snowball logo
logo
DAP_logo

Danaher Corporation

€207.50+€4.70  (2.32%)
Estimate
P/E
39.9
EPS
5.2
Beta
0.797
Growth
Revenue, YoY
29.84%
Net income, YoY
63.11%
FCF, YoY
42.77%
Dividends
Dividend yield
0.61%
Annual payout
$1.43
Next ex. div date
December 30, 26
Payout
23.49%
Div.growth, 5y
12.19%
Dividend growth streak
7 y
Div.rating
About the company
Ticker
DAP
ISIN
US2358511028
Country
United States of America
Sector (GICS)
Healthcare
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Frequently asked questions

What sector does Danaher Corporation (DAP) operate in?

Danaher Corporation belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Danaher Corporation (DAP) current stock price?

As of the latest data, Danaher Corporation stock price is €207.50, with a previous close of €202.80. Danaher Corporation gained €4.70 in the last trading session, representing a 2.32% increase.

What is Danaher Corporation (DAP) current market capitalization?

Danaher Corporation market cap is approximately 145.87 billion.

What is Danaher Corporation (DAP) Earnings Per Share (EPS)?

The trailing EPS is €5.20.

What is Danaher Corporation (DAP) Price-to-Earnings (P/E) ratio?

Danaher Corporation current P/E ratio is 39.9.

What is Danaher Corporation (DAP) EBITDA?

Danaher Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.06 billion.

Does Danaher Corporation (DAP) pay dividends?

Yes. Danaher Corporation pays quarterly dividends with an annualized yield of 0.61% and an estimated annual payout of €1.43 per share.

When is the next ex-dividend date for Danaher Corporation (DAP)?

The next ex-dividend date is scheduled for December 30, 2026.

When is Danaher Corporation (DAP) next earnings report?

Danaher Corporation is expected to release its next earnings report on September 30, 2026.

What is Danaher Corporation (DAP) beta (volatility) score?

Danaher Corporation has a beta of 0.797, indicating lower volatility than the overall market.